Study to Evaluate the Effect of Metformin in the Prevention of HG in HR[+]/HER2[-] PIK3CA-mut Advanced BC Patients

NCT04300790 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Alpelisib
DRUG: Metformin
DRUG: Fulvestrant
DRUG: Letrozole
DRUG: Exemestane
DRUG: Vildagliptin
DRUG: Tamoxifen

Sponsor

MedSIR

Collaborators

[object Object]